| Entity | Document Type | Tax ID |
|---|---|---|
| Elizabeth Glaser Pediatric AIDS Foundation | IRS Form 990 | 95-4191698 |
| Elizabeth Glaser Pediatric AIDS Foundation | Audited Financial Statements | 95-4191698 |
|
Entity: Elizabeth Glaser Pediatric AIDS Foundation Document Type: IRS Form 990 Tax ID: 95-4191698 |
|
Entity: Elizabeth Glaser Pediatric AIDS Foundation Document Type: Audited Financial Statements Tax ID: 95-4191698 |
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Charles J. Lyons, II | President/CEO | $783,045 |
| 2 | Patricia Devine Karlin | Executive VP, External Affairs & Business Development | $386,764 |
| 3 | Adriaantje Giphart | Executive VP, Medical & Scientific Affairs | $366,810 |
|
1 Name: Charles J. Lyons, II Title: President/CEO Compensation: $783,045 |
|
2 Name: Patricia Devine Karlin Title: Executive VP, External Affairs & Business Development Compensation: $386,764 |
|
3 Name: Adriaantje Giphart Title: Executive VP, Medical & Scientific Affairs Compensation: $366,810 |
According to the Elizabeth Glaser Pediatric AIDS Foundation audit of December 31, 2021 (Note 2 re: Financial Risk): "Financial instruments that potentially subject the Foundation to concentrations of credit risk consist primarily of checking accounts, certificates of deposits (CD's) and grant receivables. The Foundation maintains these checking accounts and CD's at a high credit-quality institution. Cash and certificates of deposits held at institutions insured by the Federal Deposit Insurance Corporation (FDIC) that exceeded federally insured limits or are not insured by FDIC were $10,530,273 and $9,796,275 at December 31, 2021 and 2020, respectively... "The Foundation has operations in many countries throughout the world, many of which have politically and economically volatile environments. As a result, the Foundation may have financial and operational risks associated with these operations which could negatively impact the Foundation." |
According to the Elizabeth Glaser Pediatric AIDS Foundation audit of December 31, 2021 (Note 15, Risks and Uncertainties): "On January 30, 2020, the World Health Organization (WHO) announced a global health emergency because of a new strain of coronavirus (the COVID-19 virus). On March 11, 2020, the WHO declared the novel coronavirus a global pandemic. "To further limit health risks associated with the COVID-19 virus, management has required staff at its various offices to work remotely, where required by local authorities, to mitigate further spread of the virus. The Foundation is complying with health officials in its host countries and WHO recommendations to do its part in reducing the impact to its employees. "Funding from the Foundation's U.S. Government and non-U.S. Government grants and cooperative agreements remained robust throughout 2021 with programs still being implemented in the vast majority of the Foundation's operating locations, albeit in many instances utilizing more regional personnel due to travel restrictions globally. "While there has been progress in developing and distributing COVID-19 vaccines, there continues to be uncertainty around the breadth and duration of the business disruption, as well as its impact on the global economy. Nonetheless, the Foundation will continue to monitor the financial and business implications of the pandemic on its operations and will implement new strategies as appropriate..." |
According to the Elizabeth Glaser Pediatric AIDS Foundation 2021 tax filing, the Foundation includes in its reporting for Compensation Information re: Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees, "Bonus & incentive compensation" in the amount of $150,000 paid to Charles J. Lyons II, President & CEO. His reported total compensation in 2021 is $783,045 (IRS Form 990, Schedule J, Part II).
Regarding severance payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 4a): "Severance in the amount of $18,016 was paid to Daniel Warco." Daniel Warco is reported as VP, Finance and Accounting, with total compensation of $310,395 in 2021 (IRS Form 990, Schedule J, Part II). |
